ERYTECH Pharma (ERYP) IPO Opens 15% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Erytech Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
November 10, 2017 10:01 AM ESTLYON, France--(BUSINESS WIRE)--
Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JAPAN
ERYTECH Pharma (Paris: ERYP) (ADR: EYRYY) (Euronext Paris: ERYP) (ERYTECH or the Company) announces trading resumption of its ordinary shares on Euronext Paris as from 4:00pm CET.
Trading in the ordinary shares of ERYTECH Pharma was suspended at the request of the Company on November 10, 2017 from 9:00 am CET in connection with its previously announced global offering in order to... More
ERYTECH Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market
November 10, 2017 8:06 AM ESTLYON, France--(BUSINESS WIRE)-- Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA AND JAPAN
ERYTECH Pharma (Paris: ERYP) (ADR: EYRYY) ("ERYTECH" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the pricing of its global offering to specified categories of investors of an aggregate of 5,374,033 new ordinary shares, comprising an offer of 4,686,106 ordinary shares in the form of American Depositary Shares, each representing one ordinary share ("ADSs"), in the... More
ERYTECH Announces Trading Suspension of Its Ordinary Shares on Euronext Paris
November 10, 2017 2:18 AM ESTLYON, France--(BUSINESS WIRE)--
Regulatory News:
NOT FOR DISTRIBUTION IN AUSTRALIA, CANADA OR JAPAN
Trading in the ordinary shares of ERYTECH Pharma (Euronext Paris: ERYP) (ERYTECH or the Company) (Paris: ERYP) (ADR: EYRYY), was suspended at the request of the Company on November 10, 2017 from 9:00 am CET in connection with its previously announced global offering in order to allow for the confirmation of allocations to investors and for the commencement of trading of the Companys American Depositary Shares (ADSs) on the Nasdaq Global... More
